SciELO - Scientific Electronic Library Online

 
vol.85 número4Reconstructive management of total lower lip defects with a modified gate flap at the “Dr. Eduardo Liceaga” General Hospital of MexicoFrequency and clinical association of NY-ESO-1 gene expression in diffuse large B-cell lymphoma índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Revista médica del Hospital General de México

versión On-line ISSN 2524-177Xversión impresa ISSN 0185-1063

Rev. med. Hosp. Gen. Méx. vol.85 no.4 Ciudad de México oct./dic. 2022  Epub 23-Ene-2023

https://doi.org/10.24875/hgmx.22000023 

Original articles

Association between lipid profile and gallbladder histopathology of post cholecystectomy patients

Luis D. López-Fragoso1 

María J. Corona-Torres1  2 

Natalia Nuño-Lámbarri3 

Marco A. Durán-Padilla4 

Gabriela Gutiérrez-Reyes5 

Misael Uribe-Esquivel3  6 

Jorge Lopez-López1 

David Ramirez-Tapia1 

Alejandro Rodríguez-Báez1 

Eduardo E. Montalvo-Javé1  2  6  * 

1Department of General Surgery, Hepatopancreatobiliary Surgery Clinic, Hospital General de México ‘‘Dr. Eduardo Liceaga’’

2Department of Surgery, Faculty of Medicine, Universidad Nacional Autónoma de México (UNAM)

3Translational Research Unit, Fundación Clínica Médica Sur

4Department of Pathology, Hospital General de México ‘‘Dr. Eduardo Liceaga’’

5Experimental Medicine Unit, Faculty of Medicine, UNAM

6Department of Gastroenterology, Hospital Clínica Médica Sur. Mexico City, Mexico


Abstract

Introduction:

In cholelithiasis, lipid and histopathological alterations have been found and suggest the accumulation of lipids in the gallbladder tissue (cholesterolosis), due to the few existing reports a study was carried out to determine their association.

Objectives:

The aim of the study was to evaluate the association between the lipid profile and gallbladder histopathology in patients with cholelithiasis undergoing cholecystectomy.

Methodology:

An observational, cross-sectional, analytical, and prospective study was carried out in a group of patients from the Hospital General de México “Eduardo Liceaga” undergoing elective laparoscopic cholecystectomy from January 2015 to January 2020. With approval of the protocol by the ethics and research committee, the following variables were considered: age, sex, BMI, comorbidities (diabetes, dyslipidemia, hypertension, cirrhosis), LDL-C, HDL-C, total cholesterol, triglycerides, and histopathological findings (cholesterolosis, polyps, xanthogranulomatosis, acute cholecystitis, and cholecystitis chronicle). A descriptive and inferential analysis was performed with SPSS v.24. It was considered p < 0.05 as significant.

Results:

From a group of 302 patients, 133 cases (108 women and 25 men) were included in the study. They presented overweight (39%) and obesity (33%), the lipid profile with hypoalphalipoproteinemia (61%), hypertriglyceridemia (40%), hypercholesterolemia (17%), and elevated LDL-C (16%); and in histopathology chronic cholecystitis (70%), cholesterolosis (28%), and acute cholecystitis (7%).

Discussion:

Our sample is representative of the Mexican population (in physical characteristics and lipid profile). However, no significant association was found between dyslipidemia and histopathological findings.

Keywords Lipid profile; Cholesterol; Cholesterolosis; Xanthogranulomatosis

Introduction

Cholelithiasis are hardened deposits (stones) of digestive fluid formed in the gallbladder, which are located within it or migrate to the main bile duct (MBD) and intrahepatic bile ducts. They are classified according to their composition and cholesterol stones are the most frequent with a prevalence of 10-15% in adults1,2.

Its prevalence reaches its peak between 60-70 years (30% in women and 20% in men). However, studies indicate that its global prevalence is 64.1% in women and 29.5% in men3. It is a common problem in developed countries, representing a significant health burden, in the United States (EU) between 20 and 25 million adults have it4, consuming up to $6.5 billion5,6. In Latin America, it occurs between 5 and 15%, and in Mexico 14.3% of adults present it (8.5% men and 20.5% women)7.

More than 80% of cases are asymptomatic, only 10-20% will present symptoms within 5-20 years after diagnosis. Biliary colic occurs in 1-2% per year8,9. Its complications (cholecystitis, choledocholithiasis, pancreatitis due to gallstones, and cholangitis) occur with an annual rate of 0.1-0.3%8. Among its main risk factors are obesity, a diet rich in fat and a sedentary lifestyle10,11.

Lipid profile abnormalities in patients with cholelithiasis

Altered serum lipids in cholelithiasis due to cholesterol stones suggest metabolic syndrome. More than half of patients with cholelithiasis could have a lipid disorder. It is accepted that the main event in the pathogenesis of cholesterol stones is altered lipid metabolism due to an increase in cholesterol levels compared to other lipids secreted by the liver into the bile12.

Dyslipidemia is characterized by elevated levels of total cholesterol (TC), triglycerides (TG), low-density lipoproteins (LDL), and low levels of high-density lipoproteins (HDL). Studies have shown the association between dyslipidemia and stones, especially the increase in TG and LDL13.

Channa et al. analyzed the serum lipid profile in patients with cholelithiasis and patients without cholelithiasis. They showed that elevated levels of TC, free cholesterol, LDL, TG, and reduced levels of HDL played an important role in the pathogenesis of gallstones in 45-year-old women with more than three children14.

Acute/chronic cholecystitis is a chronic relapsing hepatobiliary disease, which can result from impaired metabolism of cholesterol, bilirubin, and bile acid. Many studies have shown an association between gallstones and abnormal lipids15,16. Due to cholelithiasis, various histopathological changes are produced in the mucosa of the gallbladder (acute, chronic and granulomatous inflammation, hyperplasia, cholesterolosis, dysplasia, and carcinoma). Being symptomatic, therapeutic intervention is necessary17.

The objective of this study was to investigate the association between the histopathological finding of gallbladder lithiasis (secondary to an inflammatory process, hyperplasia, metaplasia, or carcinoma) and the lipid profile of patients undergoing laparoscopic cholecystectomy.

Material and methods

An observational, cross-sectional, analytical, and retrospective study was carried out. Records of patients over 18 years of age from the “Eduardo Liceaga” General Hospital of Mexico, who underwent laparoscopic cholecystectomy for cholelithiasis were analyzed in the period of January 2015 to January 2020. The pre-operative lipid profile was considered. Cases of patients older than 18 years of both sexes who underwent laparoscopic cholecystectomy for cholelithiasis were included in the study. Patients with incomplete clinical records were excluded from the study. The study was submitted for review by the Research Bioethics Committee of the General Hospital of Mexico “Eduardo Liceaga”. Obtaining the following variables age, sex, BMI, comorbidities (diabetes, dyslipidemia, hypertension, cirrhosis, and other), LDL-c, HDL-c, TC, TG, cholesterolosis, polyps, xanthogranulomatosis, acute cholecystitis, chronic cholecystitis, and other finding histopathological. For the statistical analysis, the IBM SPSS version 24 software was used.

Results

Three hundred and two files were reviewed, of which 133 met the inclusion criteria. Twenty-five were men and 108 women, with an average age of 42.5 ± 13.86 years. The average weight in men was 77 ± 11.91 kg and 68.43 ± 12.03 kg for women. Height was 1.68 ± 0.08 m in men and 1.56 ± 0.06 m in women. The BMI in male patients was 27.86 ± 4.0 kg/m2 and 27.92 ± 4.34 kg/m2 in female patients.

Serum levels of LDL, HDL, cholesterol, and triglycerides of patients

TC levels were 172.5 ± 41.94 mg/dl, TG 165.1 ± 114.06 mg/dl, LDL-c 110 ± 42.67 mg/dl, and HDL-c 46.8 ± 12.82 mg/dl. In addition, the proportion of patients who presented abnormal values of these lipids was analyzed. It was found that 16.5% of the patients had hypercholesterolemia (values > 200 mg/dl), 39% hypertriglyceridemia (> 150 mg/dl), 16.5% high levels of c-LDL (> 130 mg/dl), and 57.8% low levels of c-HDL (< 50 mg/dl) (Fig. 1).

Figure 1 Proportion of patients with abnormal serum values. A: cholesterol. B: triglycerides. C: LDL-c. D: HDL-c. 

Frequency of cholesterolosis, polyps, xanthogranulomatosis, acute cholecystitis, chronic cholecystitis, and other histopathological findings

Chronic cholecystitis was found in 94 cases, cholesterolosis in 38, acute and chronic cholecystitis in 10, autolysis in 8, and adenocarcinoma in one case (Fig. 2).

Figure 2 Frequency of pathologies in histopathological reports. 

Comparison between dyslipidemias and normal levels with reported pathologies

The Chi-square test was performed (CI 122-197) to evaluate the concordance between dyslipidemia with each reported pathology, without finding an association (Table 1). The four most common pathology reports were compared with dyslipidemia data, without finding an association (Table 2).

Table 1 Comparison of dyslipidemias with all pathology reports 

Pathology Total n (%) p-value
Hypercholesterolemia 22 (16.54 %) 0.07
Hypertriglyceridemia 52 (39.09 %) 0.07
High levels of LDL 22 (16.54 %) 0.07
Low levels of HDL 77 (57.89 %) 0.08

Table 2 Comparison between main findings of pathology with dyslipidemia 

Alterations in lipid profile Total n (%) p-value
Hypercholesterolemia 22 (21.35 %) 0.0614
Hypertriglyceridemia 52 (50.48 %) 0.18
High levels of LDL 22 (21.35 %) 0.17
Hypoalphalipoproteinemia 77 (74.75 %) 0.23

Discussion

In the sociodemographic characteristics of our patients, 33% presented obesity and 39% overweight, compared with the national characteristics where 39.1% presented obesity and 36.1% overweight. Regarding dyslipidemia, 17% had hypercholesterolemia, 40% hypertriglyceridemia, 16% high levels of LDL-c, and 61% low levels of HDL-c (hypoalphalipoproteinemia). In Mexico, 31% have hypercholesterolemia, 47% hypertriglyceridemia, and 55.2% hypoalphalipoproteinemia18. Histopathological reports coincide with the three phases of gallbladder inflammation from cystic duct obstruction (edema, hemorrhage, and gallbladder wall necrosis and leukocyte infiltration with subsequent wall necrosis and perforation)5.

Among the international studies with the largest number of patients is the one of Yaylak et al., who reported 429 cases. The most common report was cholesterolosis (18%), followed by acute cholecystitis (10.7%). Battha and Singh reported 287 cases demonstrating chronic cholecystitis in 73.3% of cases. In our study, the most common finding was chronic cholecystitis (70%), cholesterolosis (28%), and acute cholecystitis (7%). No significant correlation between dyslipidemia and histopathological findings was found in comparison with the study by Battha and Singh19,20. However, we highlight the findings of gastric metaplasia and adenomyomatous hyperplasia in patients with altered lipid profile.

Conclusions

Alterations in the lipid profile were not associated with the following histopathological findings: Chronic cholecystitis, cholesterolosis, and xanthogranulomatosis in patients after elective laparoscopic cholecystectomy. However, the association of dyslipidemia with gastric metaplasia and adenomyomatous hyperplasia can be studied in a larger population. It should be noted that there are few reports that list all the histopathological findings of the gallbladder in the Mexican population, despite the fact that it is a very common pathology in our country, as we have already described. This, together with the characteristics of our population (overweight, obesity, and dyslipidemia) represents an area of opportunity in studies with a greater number of cases.

REFERENCES

1. Tanaja J, Lopez RA, Meer JM. Cholelithiasis. In:StatPearls. Treasure Island (FL):StatPearls Publishing;2022. [ Links ]

2. Lammert F, Gurusamy K, Ko CW, Miquel JF, Méndez-Sánchez N, Portincasa P, et al. Gallstones. Nat Rev Dis Prim. 2016;2:16024. [ Links ]

3. Payen JL, Muscari F, Vibert E, Ernst O, Pelletier G. [Biliary lithiasis]. Presse Med. 2011;40:567-80. [ Links ]

4. Shaffer EA. Gallstone disease:epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol. 2006;20:981-96. [ Links ]

5. Gallaher JR, Charles A. Acute cholecystitis. Clinical review. JAMA. 2022;327:965-75. [ Links ]

6. Shaffer EA. Epidemiology and risk factors for gallstone disease:has the paradigm changed in the 21st century?Curr Gastroenterol Rep. 2005;7:132-40. [ Links ]

7. Almora CL, Prado YA, González TP, Ferro YP, Hernández ZH. Diagnóstico clínico y epidemiológico de la litiasis vesicular. Revisión bibliográfica. Rev Cien Méd Pinar Río. 2012;16:200-14. [ Links ]

8. Pedersen G, Hoem D, Andrén-Sandberg A. Influence of laparoscopic cholecystectomy on the prevalence of operations for gallstones in Norway. Eur J Surg. 2002;168:464-9. [ Links ]

9. Yoo KS. Management of gallstone. Korean J Gastroenterol. 2018;71:253-9. [ Links ]

10. Casper M, Lammert F. Gallstone disease:basic mechanisms, diagnosis and therapy. Praxis (Bern 1994). 2011;100:1403-12. [ Links ]

11. Ruhl CE, Everhart JE. Gallstone disease is associated with increased mortality in the United States. Gastroenterology. 2011;140:508-16. [ Links ]

12. Batajoo H, Hazra NK. Analysis of serum lipid profile in cholelithiasis patients. J Nepal Health Res Counc. 2013;11:53-5. [ Links ]

13. Wang J, Shen S, Wang B, Ni X, Liu H, Ni X, et al. Serum lipid levels are the risk factors of gallbladder stones:a population-based study in China. Lipids Health Dis. 2020;19:50. [ Links ]

14. Channa NA, Ghanghro AB, Soomro AM. Quantitative analysis of serum lipid profile in gallstone patients and controls. Pak J Anal Environ Chem. 2010;11:7. [ Links ]

15. Hayat S, Hassan Z, Changazi SH, Zahra A, Noman M, Ul Abdin M, et al. Comparative analysis of serum lipid profiles in patients with and without gallstones:a prospective cross-sectional study. Ann Med Surg (Lond). 2019;42:11-3. [ Links ]

16. Shabanzadeh DM. Incidence of gallstone disease and complications. Curr Opin Gastroenterol. 2018;34:81-9. [ Links ]

17. Sing A, Singh G, Kaur K, Goyal G, Saini G, Sharma D. Histopathological changes in gallbladder mucosa associated with cholelithiasis:a prospective study. Niger J Surg. 2019;25:21-5. [ Links ]

18. ENSANUT. Encuesta Nacional de Salud y Nutrición 2018-19. SS México:ENSANUT. [ Links ]

19. Bhatta S, Singh S. Study of gallbladder lesions and its relationship with serum lipid profile. Int J Adv Med. 2018;5:1245-9. [ Links ]

20. Yaylak F, Deger A, Ucar BI, Sonmez Y, Bayhan Z, Yetisir F. Cholesterolosis in routine histopathological examination after cholecystectomy:what should a surgeon behold in the reports?Int J Surg. 2014;12:1187-91. [ Links ]

FundingThis study has not received specific aid from public sector organizations, the commercial sector, or non-profit entities.

Ethical disclosures

Protection of people and animals. The authors declare that no experiments have been performed on humans or animals for this research.

Data confidentiality. The authors declare that they have followed the protocols of their work center on the publication of patient data.

Right to privacy and informed consent. The authors declare that no patient data appear in this article.

Received: May 31, 2022; Accepted: September 07, 2022

* Correspondence: Eduardo E. Montalvo-Javé E-mail: montalvoeduardo@hotmail.com

Conflicts of interest

The authors declare that they have no conflicts of interest.

Creative Commons License Sociedad Médica del Hospital General de Mexico. Published by Permanyer. This is an open access article under the CC BY-NC-ND license